Hypoxia-inducible factor prolyl hydroxylase 2 (EGLN1; HIF-PH2; PHD2) BriefCommunication Pages: 309 - 309
Mammalian target of rapamycin (mTOR; FRAP; RAFT1); eukaryotic translation initiation factor 4E (EIF4EBP1; 4EBP1) BriefCommunication Pages: 311 - 311
Muscle RAS oncogene homolog (MRAS); HNF1 homeobox A (HNF1A); solute carrier family 22 (extraneuronal monoamine transporter), member 3 (SLC22A3); lipoprotein, Lp(a)-like 2 (LPAL2); lipoprotein, Lp(a) (LPA); SNP rs9818870; SNP rs2259816; SNP rs2048327; SNP rs3127599; SNP rs7767084; SNP rs10755578 BriefCommunication Pages: 314 - 314
ADAM metallopeptidase with thrombospondin type 1 motif 18 (ADAMTS18) BriefCommunication Pages: 316 - 316
Complement factor H (CFH); genome-derived neisserial antigen 1870 (GNA1870; fHbp; R2086) BriefCommunication Pages: 320 - 320
Monocyte chemoattractant protein-1 (MCP-1; CCL2); chemokine (C-C motif) receptor 2 (CCR2); integrin α4 (ITGA4); P selectin (SELP; CD62P) BriefCommunication Pages: 322 - 322
Tumor necrosis factor receptor superfamily, member 21 (TNFRSF21; DR-6); caspase-6 apoptosis-related cysteine peptidase (CASP6; MCH2); amyloid precursor protein (APP) BriefCommunication Pages: 328 - 328
pH-sensitive, pegylated nanoparticles for small interfering RNA delivery BriefCommunication Pages: 338 - 338
Striated muscle-specific adeno-associated viral (AAV) vectors for targeted gene delivery BriefCommunication Pages: 339 - 339
Vaccination via delivery of dendritic cell (DC)-targeted protective antigens BriefCommunication Pages: 342 - 342
